|
Clinicopathologic factors
|
Number of patients (%)
|
|---|
|
Histologic type
|
|
Serous
|
140 (56.5)
|
|
Mucinous
|
47 (19.0)
|
|
Endometrioid
|
19 (7.7)
|
|
Clear
|
42 (16.9)
|
|
Residual tumor
|
|
Optimal
|
167 (90.8)
|
|
Suboptimal
|
17 (9.2)
|
|
Tumor grade
|
|
1
|
57 (23.0)
|
|
2
|
122 (49.2)
|
|
3
|
69 (27.8)
|
|
Tumor stage
|
|
Early
|
68 (37.2)
|
|
Advanced
|
115 (62.8)
|
|
Nuclear grade
|
|
Mild and moderate
|
137 (55.2)
|
|
Marked
|
111 (44.8)
|
|
Mitosis
|
|
0–9/10 HPFs
|
93 (37.5)
|
|
10–24/10 HPFs
|
95 (38.3)
|
|
> =25/10 HPFs
|
60 (24.2)
|
|
Chemoresponse
|
|
Regressive disease
|
73 (43.5)
|
|
Stable/progressive disease
|
95 (56.5)
|
